Efficiency and safety of tocolytic therapy with hexoprenaline depending on body mass index in pregnant women

Gureeva L.V.; Chistyakova O.M.; Grebenshchikova L.Yu.; Kolbasnikov S.V.; Rad’kov O.V.

doi:https://doi.org/10.17116/rosakush20212104175

Gureeva L.V.

Tver State Medical University

Chistyakova O.M.

Tver State Medical University

Grebenshchikova L.Yu.

Tver State Medical University

Kolbasnikov S.V.

Tver State Medical University

Rad’kov O.V.

Tver State Medical University

Efficiency and safety of tocolytic therapy with hexoprenaline depending on body mass index in pregnant women

Authors:

Gureeva L.V., Chistyakova O.M., Grebenshchikova L.Yu., Kolbasnikov S.V., Rad’kov O.V.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2021;21(4): 75‑80

DOI: 10.17116/rosakush20212104175

Read: 1322 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Gureeva LV, Chistyakova OM, Grebenshchikova LYu, Kolbasnikov SV, Rad’kov OV. Efficiency and safety of tocolytic therapy with hexoprenaline depending on body mass index in pregnant women. Russian Bulletin of Obstetrician-Gynecologist. 2021;21(4):75‑80. (In Russ.)
https://doi.org/10.17116/rosakush20212104175

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To evaluate the efficacy and safety of the tocolysis with hexoprenaline application in pregnant women depending on the body mass index (BMI).

MATERIAL AND METHODS

Patients with threatened preterm childbirth who received hexoprenaline for tocolysis were divided into two groups: non-obese (n=71, group 1) and obese (n=53, group 2). The analysis of efficiency indicators, the frequency of adverse effects of tocolysis, Holter ECG monitoring and biochemical assays were performed.

RESULTS

The indicators of the effectiveness of tocolysis with hexoprenaline in the groups did not differ significantly. Adverse effects of tocolysis (nausea and tremor) were significantly more frequent in pregnant women with normal BMI than in obese patients. According to the data of 24-hour ECG monitoring in both groups of patients there was a decrease in the variability of the cardiac rhythm but in obese pregnant women, the vagal effects on the heart rhythm significantly decreased and the frequency of cardiac arrhythmias increased. Among obese patients during tocolysis with hexoprenaline the level of lipid and glucose fractions in the blood was significantly higher than in non-obese pregnant women.

CONCLUSION

The frequency of adverse effects, indicators of regulation of the cardiovascular system and metabolism during tocolysis with hexoprenaline depend on the BMI in pregnant women. When using tocolytic therapy with a beta-adrenomimetic it is necessary to take into consideration the presence or absence of obesity in patient.

Keywords:

premature childbirth

hexoprenaline

obesity

Authors:

Gureeva L.V.

Tver State Medical University

Chistyakova O.M.

Tver State Medical University

Grebenshchikova L.Yu.

Tver State Medical University

Kolbasnikov S.V.

Tver State Medical University

Rad’kov O.V.

Tver State Medical University

Received:

29.09.2020

Accepted:

21.12.2020

Close metadata

References:

Preterm birth. WHO, 2015. https://doi.org/10.7551/mitpress/10389.003.0006
ACOG Practice. Bulletin No. 171: Management of preterm labor. Obstet Gynecol. 2016;128:4:e155—164. https://doi.org/10.1097/AOG.0000000000001711
Granese R, Gitto E, D'Angelo G, Falsaperla R, Corsello G, Amadore D, Calagna G, Fazzolari I, Grasso R, Triolo O. Preterm birth: seven-year retrospective study in a single centre population. Ital J Pediatr. 2019;45:1:45. https://doi.org/10.1186/s13052-019-0643-9
Liu B, Xu G, Sun Y, Du Y, Gao R, Snetselaar LG, Santillan MK, Bao W. Association between maternal pre-pregnancy obesity and preterm birth according to maternal age and race or ethnicity: a population-based study. Lancet Diabetes Endocrinol. 2019;7:9:707-714. https://doi.org/10.1016/S2213-8587(19)30193-7
Tsur A, Mayo JA, Wong RJ, Shaw GM, Stevenson DK, Gould JB. ‘The obesity paradox’: a reconsideration of obesity and the risk of preterm birth. J Perinatol. 2017;37:10:1088-1092. https://doi.org/10.1038/jp.2017.104
Baev OR, Vasil’chenko ON, Karapetyan AO. Modern tocolysis and adverse effects of tocolytics. Ginekologiya. 2018;20:2:46-50. (In Russ.). https://doi.org/10.26442/2079-5696_2018.2.46-50
Rath W, Kehl S. Acute tocolysis - a critical analysis of evidence-based data. Geburtshilfe Frauenheilkd. 2018; 78: 12: 1245-1255. https://doi.org/10.1055/a-0717-5329
Tersigni C, Neri C, D’Ippolito S, Garofalo S, Martino C, Lanzone A, Scambia G, Di Simone N. Impact of maternal obesity on the risk of preterm delivery: insights into pathogenic mechanisms. J Matern Fetal Neonatal Med. 2020;1-6. https://doi.org/10.1080/14767058.2020.1817370
de Heus R, Mol BW, Erwich JJ, van Geijn HP, Gyselaers WJ, Hanssens M, Härmark L, van Holsbeke CD, Duvekot JJ, Schobben FF, Wolf H, Visser GH. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ. 2009;338:b744. https://doi.org/10.1136/bmj.b744
Di Renzo GC, Cabero Roura L, Facchinetti F, Helmer H, Hubinont C, Jacobsson B, Jørgensen JS, Lamont RF, Mikhailov A, Papantoniou N, Radzinsky V, Shennan A, Ville Y, Wielgos M, Visser GHA. Preterm labor and birth management: recommendations from the European Association of Perinatal Medicine. J Matern Fetal Neonatal Med. 2017;30:17:2011—2030. https://doi.org/10.1080/14767058.2017.1323860
Shigemi D, Aso Sh, Yasunaga H. Inappropriate use of ritodrine hydrochloride for threatened preterm birth in Japan: a retrospective cohort study using a national inpatient database. BMC Pregnancy Childbirth. 2019;19:1:204. https://doi.org/10.1186/s12884-019-2352-1
Kim MK, Lee SM, Oh JW, Kim SY, Jeong HG, Kim SM, Park CW, Jun JK, Hahn SK, Park JS. Efficacy and side effect of ritodrine and magnesium sulfate in threatened preterm labor. Obstet Gynecol Sci. 2018;61:1:63-70. https://doi.org/10.5468/ogs.2018.61.1.63
Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database of Systematic Reviews. 2014;2:CD004352. https://doi.org/10.1002/14651858.CD004352.pub3
Obstetrics. National guide. Ed. Savel’eva G.M., Sukhikh G.T., Serov V.N., Radzinskii V.E. M.: GEOTAR-Media Publ; 2019. (In Russ.).
Sukhikh GT, Serov VN, Adamyan LV, Filippov OS, Baev O., Klimenchenko NI, Tetruashvili NK, Tyjutyunnik VL, Hodzhaeva ZS, Holin AM. Preterm labour. Problemy reproduktsii. 2018;24:S6:56-79. (In Russ.).
Baev O.R., Vasil'chenko O.N., Karapetyan A.O. Baev M.O. Comparison of tocolysis with atosiban and hexoprenaline in premature delivery before 32 and after 32 weeks of pregnancy. Meditsinskii sovet. 2017;13:80—84. (In Russ.). https://doi.org/10.21518/2079-701X-2017-13-80-85
Yoneda S, Yoneda N, Fukuta K, Shima T, Nakashima A, Shiozaki A, Yoshino O, Kigawa M, Yoshida T, Saito S. In which preterm labor-patients is intravenous maintenance tocolysis effective? J Obstet Gynaecol Res. 2018;44:3:397-407. https://doi.org/10.1111/jog.13547
Chung JE, Choi SA, Hwang HS, Park JY, Lee KE, Yee J, Kim YJ, Gwak HS. Association between β2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study. BMC Genet. 2017;18:1:96. https://doi.org/10.1186/s12863-017-0565-8
Vesalainen RK, Ekholm EM, Jartti TT, Tahvanainen KU, Kaila TJ, Erkkola RU. Effects of tocolytic treatment with ritodrine on cardiovascular autonomic regulation. Br J Obstet Gynaecol. 1999;106:3:238-243. https://doi.org/10.1111/j.1471-0528.1999.tb08237.x
Solanki JD, Desai FH, Desai KH. Heart rate variability is reduced in normal pregnancy irrespective of trimester: A cross-sectional study from Gujarat, India. J Family Med Prim Care. 2020;9:2:626—631. https://doi.org/10.4103/jfmpc.jfmpc_1123_19